Journal ID (nlm-ta): PLoS One
Journal ID (iso-abbrev): PLoS ONE
Journal ID (publisher-id): plos
Journal ID (pmc): plosone
Title:
PLoS ONE
Publisher:
Public Library of Science
(San Francisco, CA USA
)
ISSN
(Electronic):
1932-6203
Publication date
(Electronic):
10
November
2015
Publication date Collection: 2015
Volume: 10
Issue: 11
Electronic Location Identifier: e0142600
Affiliations
[1
]Department of Neurology, University of California San Francisco, San Francisco, California,
United States of America
[2
]Department of Neurology, Yale University, New Haven, Connecticut, United States of
America
[3
]Huntington Medical Research Institutes, Pasadena, California, United States of America
[4
]South East Asia Research Collaboration with Hawaii, The Thai Red Cross AIDS Research
Centre, Bangkok, Thailand
[5
]Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
[6
]Department of Retrovirology, Armed Forces Research Institute of Medical Sciences,
United States Component, Bangkok, Thailand
[7
]United States Military HIV Research Program, Walter Reed Army Institute of Research,
Silver Spring, Maryland, United States of America
[8
]Department of Biostatistics and Epidemiology, University of California San Francisco,
San Francisco, California, United States of America
[9
]Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland,
United States of America
Pacific Northwest National Laboratory, UNITED STATES
Author notes
Competing Interests: Dr. Valcour has recently served as a consultant to ViiV Healthcare, who have supported
antiretrovirals for this study but have not had input on the analyses or the manuscript.
The authors also note that The Thai Government Pharmaceutical Organization (tenofovir,
lamivudine, efavirenz), Gilead (Truvada, Atripla), Merck (Sustiva, Isentress), and
ViiV Healthcare (Selzentry) provided antiretroviral therapy. This does not alter the
authors' adherence to PLOS ONE policies on sharing data and materials.
Conceived and designed the experiments: VGV SSS NP JHK JA. Performed the experiments:
NP JLKF EDMBK PP JMH JA. Analyzed the data: VGV SSS JA IEA. Contributed reagents/materials/analysis
tools: VGV SSS NS NP SL JLKF EDMBK LLJ IEA CLA PP BMS JMH JHK JA. Wrote the paper:
VGV SSS NS NP SL JLKF EDMBK LLJ IEA CLA PP BMS JMH JHK JA.
¶ Membership of the SEARCH 010/RV 254 Study Group is provided in the Acknowledgments.
Article
Publisher ID:
PONE-D-15-20473
DOI: 10.1371/journal.pone.0142600
PMC ID: 4640512
PubMed ID: 26555069
SO-VID: 315074d9-c781-40eb-b7c1-a5c974ed6862
License:
This is an open access article, free of all copyright, and may be freely reproduced,
distributed, transmitted, modified, built upon, or otherwise used by anyone for any
lawful purpose. The work is made available under the
Creative Commons CC0 public domain dedication
This work is supported by R21MH086341 from the National Institutes of Health (VV),
R01MH095613 from the National Institutes of Health (VV & SS), and a cooperative agreement
(W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of
Military Medicine, Inc., and the U.S. Department of Defense (DoD) which includes support
from the National Institutes of Mental Health. The views expressed are those of the
authors and should not be construed to represent the positions of the US Army or the
Department of Defense or views of the National Institutes of Health. The authors received
additional funding from the Intramural research programs of the National Institute
of Allergy and Infectious Diseases and of the Vaccine and Gene Therapy Institute.
The Thai Government Pharmaceutical Organization (tenofovir, lamivudine, efavirenz),
Gilead (Truvada, Atripla), Merck (Sustiva, Isentress), and ViiV Healthcare (Selzentry)
provided antiretroviral therapy. The funders had no role in study design, data collection
and analysis, decision to publish, or preparation of the manuscript.